Form 4: ResMed CEO Michael Farrell Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
ResMed's CEO, Michael J. Farrell, exercised stock options and sold shares of ResMed Common Stock on August 7, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On August 7, 2024, Michael J. Farrell, the CEO of ResMed Inc., executed stock options for 14,683 shares of ResMed Common Stock at a price of $84.98 per share.
- Concurrently, Farrell sold 14,683 shares of ResMed Common Stock at a weighted average price of $214.2549, with individual sales prices ranging from $210.31 to $219.11.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on January 31, 2024.
- Following these transactions, Farrell directly owns 440,799 shares of ResMed Common Stock.
- He also indirectly owns 4,090 shares through the Lisette and Michael Farrell Family Trust and an unspecified amount through the Lisette and Michael Farrell Foundation.
- After the transaction, Farrell directly owns 44,049 ResMed Common Stock Options.
Sentiment
Score: 5
Explanation: The document describes routine transactions under a pre-arranged trading plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of a 10b5-1 plan allows insiders to sell shares without being accused of trading on non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by the CEO, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 01/31/2024 | Date the Rule 10b5-1 plan was adopted. |
| 08/07/2024 | Date of the stock option exercise and share sale. |
| 08/08/2024 | Date of signature on the Form 4 filing. |
| 11/16/2024 | Expiration date of the ResMed Common Stock Options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.